chr3-52694042-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014366.5(GNL3):āc.1506C>Gā(p.Asn502Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000752 in 1,613,298 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_014366.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GNL3 | NM_014366.5 | c.1506C>G | p.Asn502Lys | missense_variant | 14/15 | ENST00000418458.6 | |
GNL3 | NM_206825.2 | c.1470C>G | p.Asn490Lys | missense_variant | 14/15 | ||
GNL3 | NM_206826.1 | c.1470C>G | p.Asn490Lys | missense_variant | 14/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GNL3 | ENST00000418458.6 | c.1506C>G | p.Asn502Lys | missense_variant | 14/15 | 1 | NM_014366.5 | P2 | |
GNL3 | ENST00000394799.6 | c.1470C>G | p.Asn490Lys | missense_variant | 14/15 | 2 | A2 | ||
GNL3 | ENST00000496254.5 | n.1790C>G | non_coding_transcript_exon_variant | 13/14 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152184Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000354 AC: 89AN: 251384Hom.: 0 AF XY: 0.000361 AC XY: 49AN XY: 135870
GnomAD4 exome AF: 0.000783 AC: 1144AN: 1460996Hom.: 0 Cov.: 31 AF XY: 0.000717 AC XY: 521AN XY: 726856
GnomAD4 genome AF: 0.000460 AC: 70AN: 152302Hom.: 1 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74462
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at